Shaping the future of animal health
Virbac group
Archive
Finance contact
Investor Relations
Virbac
13e rue LID - BP 27
F 06511 Carros cedex
Fax: +33 4 92 08 76 58
 
Virbac in 3 minutes

Public releases 2016

2016 Annual consolidated sales

Tuesday, January 17, 2017 

Public release

 

Annual sales growth of 4.5%, at constant exchange rates

Read more

St. Louis: lifting of the Warning Letter for the Virbac production site

Friday, December 16, 2016 

Public release

Virbac announces that it has received from the Food and drug administration (FDA) a communication confirming the lifting of the Warning Letter received in December 2015 for its St. Louis production site (Missouri, USA).

Read more

2016 third quarter consolidated sales

Thursday, October 13, 2016 

Public release

 

Sales grow by 3.2% at the end of September at constant rates

Read more

2016 half year results

Monday, September 19, 2016 

Public release

 

Growth of half-year results

Read more

2016 second quarter consolidated sales

Monday, July 18, 2016 

Public release

 

Sales growth by 3.6% at constant exchange rates in the first half

Read more

Habib Ramdani appointed chief financial officer at Virbac and member of the executive board

Wednesday, June 29, 2016 

Public release

Habib Ramdani appointed chief financial officer at Virbac and member of the executive board

Virbac announces the appointment of Habib Ramdani as chief financial officer. Appointed to the executive board on June 23, 2016, Habib has overseen all financial activities of the Group since taking office on May 2, 2016, reporting directly to Éric Marée, chairman of the Virbac group executive board.

Read more

2016 first quarter consolidated sales

Wednesday, April 13, 2016 

Public release

 

Sales in the first quarter 2016 : return to organic growth

Read more